High-risk human papillomavirus (HR-HPV) and cervical intraepithelial neoplasia (CIN) in Mexican women of two hospitals;Virus de papiloma humano de alto riesgo (VPH-AR) y neoplasia intraepitelial cervical (NIC) en mujeres de dos hospitales de la Ciudad de México

Revista de Investigacion Clinica

Volumn 54, Issue 4, 2002, Pages 299-306

  Hernández Hernández, Dulce Ma ^a   García Carrancá, Alejandro ^a   Guido Jiménez, Miriam C ^a   González Sánchez, José Luis ^a   Cruz Talonia, Fernando ^a   Apresa García, Teresa ^a   Martínez Elizondo, Olga A ^a   Ornelas Bernal, Laura ^a   Alvarado Cabrera, Isabel ^a   Muñoz, Sergio ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Cervical intraepithelial neoplasia (CIN); Human papilloma virus (HPV); Hybrid capture II

Indexed keywords

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH INSURANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEXICO; PATIENT INFORMATION; PATIENT REFERRAL; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

ADULT; BIOPSY; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HOSPITALS, GENERAL; HOSPITALS, PUBLIC; HUMANS; MEXICO; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK FACTORS; URBAN POPULATION; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VIRULENCE;

EID: 17544393250     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Secretaría de Salud, SSA. Mortalidad 1994. Secretaría de Planeación. Dirección General de Estadística e Informática. México 1996: 44-5.
2. Parkin DM, Muir CS, Whelan SL, et al. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 1992; 120: 45-173.
3. WHO. The World Health Report Geneva: WHO, 1997.
4. Ponten J, Guo Z. Pre-cancer of the human cervix. Cancer Surv 1998; 32: 201-29.
5. Buckley CH, Butler EB, Fox H. Cervical intraepithelial neoplasia. J Clin Pathol 1982; 35: 1-13.
6. Kjaer KS, Van Den Brule Adriaan JC, Bock E, Poll PA, Engholm G, Sherman ME, Walboomers JMM, Meijer CJLM. Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996; 65: 601-6.
7. Koutsky L. Role of epidemiology in defining events that influence transmission and natural history of anogenital papillomavirus infections. J Natl Cancer 1991; 83: 978-9.
8. Muñoz N, Bosch FX. HPV and cervical neoplasia: Review of case-control and cohort studies. IARC Sci Publ 1992: 119: 251-61.
9. Mitchel MF, Tortolero LG, Wright T, Sarkar A, Richards KR, Hong KW, Schottenfeld D. Cervical human papillomavirus and intraepithelial neoplasia. Natl Cancer Inst Monogr 1996; 17-25.
10. Bosh FX, Muñoz N, De Sanjosé S, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in si tu: A case control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2: 415-22.
11. Olsen AO, Gjoen K, Sauer T, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III; a population based case-control study. Int J Cancer 1995; 61: 312-5.
12. Schiffman M, Bauer H, et al. Epidemiologic evidence showing that HPV infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 8: 958-64.
13. Sasagawa T, Dong Y, Saijoh K, Satake S, Tateno M. Human papillomavirus infection and risk determinats for squamous intraepithelial lesion and cervical cancer in Japan. JPN J Cancer Res 1997; 88(4): 376-84.
14. Palefski JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev 1995; 4: 415-28.
15. Ferrera A, Velema JP, Figueroa M, Bulnes R, Toro LA, Claros JM, De Barahona O, Melchers WJ. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: A case-control study. Int J Cancer 1999; 82: 799-803.
16. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P, von Knebel DM. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999; 59: 6132-6.
17. Berumen J, Unger RE, Casas L, Figueroa P. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 1995; 26: 676-81.
18. Keng Ling Chua, Anders Hjerpe. Persistence of human papillomavirus (HPV) infections preceeding cervical carcinoma. Cancer 1996; 77: 121-7.
19. Koutsky LA, Holmes KK, Crithclow CW, Stevens C, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat B. Cohort study of risk of cervical intraepithelial neoplasia grade 2 or 3 associated with cervical papillomavirus infection. New Engl J Med 1992; 327: 1272-8.
20. Henry M. The Bethesda System. The pathology of preinvasive lesions and screening technology. Natl Cancer Inst Monogr 1996; 1: 13-6.
21. Kiviat N. Natural history of cervical neoplasia: Overview and update. Am J Obstet Gynecol 1996; 175: 1099-4.
22. Schneider A, Koutsky A. Natural history and epidemiological features of genital HPV infection. International Agency for Research on Cancer (WHO) 119 Scientific Publications 1992: 25-52.
23. Moscicki AB, Winkler B, Irwin CE, Schachter J. Differences in biologic maturation, sexual behavior and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia. J Pediatr 1989; 115: 487-93.
24. Kataja V, Syrjänen S, Yli Skosky M, et al. Risk factors associated with cervical human papillomavirus infection, a case control study. Am J Epidemiol 1993; 735-45.
25. Winkelstein WJr. Smoking and cervical cancer-current status: A review. Am J Epidemiol 1990; 131: 945-57.
26. Phillips AN, Davey-Smith G. Cigarrette smoking as a potential cause of cervical cancer: Has confounding been controlled. Int J Epidemiol 1994; 23: 42-9.
27. Koss LG, Marks PA, Turler H, Weil R. Precursor lesions of carcinoma of uterine cervix in precancerous lesions: A multidisciplinary approach. 1993: 5-25.
28. Torroella KM, Morsberger S, Carrrillo a, Mohar A, Meneses A, Ibarra M, Daniel RW, Ghaffari AM, Solorza G, Shah KV. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 1998; 70: 115-20.
29. Hernández AM, Lazcano PEC, Berumen CJ, Cruz VA, Alonso de Ruiz PP, González LG. Human papillomavirus 16-18 infection and cervical cancer in Mexico: A case control study. Arch Med Res 1997; 28: 265-71.
30. Secretaría de Salud. Subsecretaría de Coordinación y Desarrollo. Dirección General de Epidemiología. Registro Nacional del Cáncer. Compendio de información sobre morbilidad por cáncer cervicouterino en México 1975-1992. México: 1994: 89.
31. Bronfman M, Guiscafré H, Castro V, Castro R. La medición de la desigualdad. Una estrategia metodológica. Análisis de las características socioeconómicas de la muestra. Arch Invest Med Mex 1988; 19: 351-60.
32. Hernández HDM, García ER, Ornelas BL, Hernández AF, González LG, Martínez GMC. Factors associated with non-use of Pap test. A population survey. Arch Med Res 1998; 29: 263-70.
33. Digene Corporation. Digene HPV test Hybrid Capture II. A signal amplification hybridization micropalte test for the chemiluninescent detection and quantitation of human papillomavirus (HPV) DNA. 1998.
34. Cox TJ, Lórincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172: 946-54.
35. Statistical Package for Social Sciences (SPSS), México. 1999.
36. Kleinbaum DG, Kupper LL, Morgenstern H. Applications of logistic regression with interaction, using unconditional ML estimation. In: Epidemiologic research, principles and quantitative methods. New York: Van Nostrand Reinhold; 1982, p. 472-507.
37. Fait G, Kupferminic MJ, Daniel Y, Geva E, Ron IG, Lessing JB, Bar-Am Amiram. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral. Gynecol Oncol 2000; 79: 177-80.
38. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutxhinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 464-74.
39. Tabrizi SN, Fairley CK, Chen S, Borg AJ, Baghurst P, Quinn MA, Garland SM. Epidemiological characteristics of women with high grade CIN who do and do not have human papillomavirus. Br J Obstet Gynecol 1999; 106: 252-7.
40. Giuliano AR, Papenfuss M, Schneider A, Nour M, Hatch K. Risk factors for high-risk type human papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev 1999; 8: 615-20.
41. Secretaría de Salud. Programa de prevención y control del cáncer cérvico uterino 1998-2000. México 1998: 5.
42. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J. Sexual behavior and smoking as determinants of cervical HPV infection and of CIN3 among those infected: A case-control study nested within the Manchester cohort. Br J Cancer 2000; 88: 1565-72.
43. Carozzi F, Ronco G, Confortini M, Noferini D, Maddau C, Ciatto S, Segnan N. Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J Cancer 2000; 83: 1462-7.
44. Paraskevaidis E, Kalantaridou SN, Georgiou I, Koliopoulos G, Pappa L, Malamou-Mitsi V, Agnantis NJ, Kitchener HC, Lolis DE. Spontaneous evolution of human papillomavirus infection in the uterine cervix. Anticancer Res 2000; 19: 3473-8.
45. Josefsson AM, Magnusson PKE, Ylitalo N, Serensen P, Qwarforth-Tubbin P, Kragh AP, Melbye M, Hans-Olov A, Gyllensten UB. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study. Lancet. 2000; 255: 2194-8.
46. Odunsi K, Terry G, Ho Linda, Bell J, Cuzick J, Ganesan TS. Susceptibility to human papillomavirus-associated cervical intraepithelial neoplasia is determined by specific HLA DR-DQ alleles. Int J Cancer 1996; 67: 595-602.